Approved Antibody-Drug Conjugates: Key Takeaways and Lessons Learned

On September 13, 2024, Ravi Chari, Ph.D., will host a GEN Learning Lab webinar, discussing 12 FDA-approved antibody-drug conjugates (ADCs), their mechanisms of action, clinical relevance, and development learning experiences. The designs and selection of ADC components, the antibody, linker, and payloads will be highlighted, followed by a live Q&A session.